FrancophonIA/ELRC3.0 huggingface dataset:
English: If the solution looks cloudy, discoloured or has particles, throw the pre-filled syringe away in a puncture resistant (sharps) container, and use a new pre-filled syringe.
Croatian: Ako otopina izgleda zamućeno, ako je promijenila boju ili sadrži čestice, bacite napunjenu štrcaljku u spremnik za oštre predmete i upotrijebite novu napunjenu štrcaljku.
English: Do not remove the needle cap until right before you inject.
Croatian: Nemojte skidati kapicu igle dok niste spremni za primjenu injekcije.
English: Push firmly on the plunger at the end of the injection.
Croatian: Na kraju injiciranja čvrsto pritisnite klip.
English: Make sure the needle stays fully inserted in the injection site while you are injecting the medicine.
Croatian: Morate paziti da igla ostane potpuno uvedena tijekom injiciranja lijek.
English: Caution should be used with anithrombotic medicinal products, antiplatelet medicinal products, and medicinal products that may lower platelet count, for example acetylsalicyclic acid, clopidogrel, warfarin, heparin, low-molecular weight heparins, Factor Xa inhibitors such as rivaroxaban and apixaban, and thrombin inhibitors such as dabigatran (see section 4.4).
Croatian: Potreban je oprez s antitrombotskim lijekovima, antitrombocitnim lijekovima te lijekovima koji mogu smanjiti broj trombocita, npr. acetilsalicilatna kiselina, klopidogrel, varfarin, heparin, heparin male molekularne mase, inhibitori faktora Xa kao što su rivaroksaban i apiksaban te inhibitori trombina kao što je dabigatran (vidjeti dio 4.4).
English: Primary Endpoint Analysis mNIS+7 and Norfolk QoL-DN
Croatian: Tablica 4. Analiza primarnih mjera ishoda, mNIS+7 i Norfolk QoL-DN
English: If you are taking any medicines that can lower platelet count or stop blood from clotting, for example acetylsalicylic acid, clopidogrel, warfarin, heparin, rivoraxaban and dabigatran, you must tell your doctor before you use Tegsedi.
Croatian: Ako uzimate lijekove koji mogu smanjiti broj trombocita ili zaustaviti zgrušavanje krvi, na primjer acetilsalicilatna kiselina, klopidogrel, varfarin, heparin, rivoraksaban i dabigatran, morate obavijestiti liječnika prije nego primijenite Tegsedi.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 284 mg inotersen (as sodium).
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna napunjena štrcaljka sadrži 284 mg inotersena (u obliku inotersennatrija).
English: Inotersen is associated with reductions in platelet count, which may result in thrombocytopenia (see section 4.8).
Croatian: Inotersen je povezan sa smanjenim brojem trombocita, što može rezultirati trombocitopenijom (vidjeti dio 4.8).
English: Stage I Disease
Croatian: 1. stadij bolesti
English: Do not try to replace the cap on the retracted needle.
Croatian: Nemojte pokušavati vratiti kapicu na uvučenu iglu.
English: (haematoma) - Itching - Rash - Kidney damage leading to poor kidney function or kidney failure - Changes to your blood and urine test results (this may indicate infection or liver or kidney damage) - Flu like symptoms, such as high temperature, aches and chills (influenza-like illness) - Injection site swelling or skin discolouration
Croatian: (hematom) - svrbež - osip - oštećenje bubrega koje dovodi do slabe bubrežne funkcije ili zatajivanja bubrega - promjene u rezultatima pretraga krvi i mokraće (to može ukazivati na infekciju ili oštećenje jetre ili bubrega) - simptomi nalik gripi, kao što su visoka temperatura, bolovi i zimica (bolest nalik gripi)
English: Patients should be monitored for thrombocytopenia during treatment with inotersen (see section 4.4).
Croatian: Bolesnike treba nadzirati kako bi se uočila trombocitopenija tijekom liječenja inotersenom (vidjeti dio 4.4).
English: You should see your doctor immediately if you have unexplained bruising or a rash of small patches of red appearing on the skin (called petechiae), bleeding from skin cuts that does not stop or oozes, bleeding from the gums or nose, blood in urine or stools, bleeding in the whites of your eyes.
Croatian: Morate se odmah obratiti liječniku ako imate neobjašnjiv nastanak modrica ili osipa u obliku malih crvenih mrlja koje se pojavljuju na koži (nazivaju se petehije), krvarenje iz posjekotina na koži koje ne prestaje ili curi, krvarenje desni ili iz nosa, krv u mokraći ili stolici, krvarenje iz bjeloočnica.
English: If you are planning to become pregnant you should stop taking inotersen including vitamin A supplementation and ensure that your vitamin A levels have returned to normal before conception is attempted.
Croatian: Ako planirate zatrudnjeti, morate prestati uzimati inotersen, uključujući i dodatke vitamina A, i osigurati da su Vam se razine vitamina
English: Do not use if the solution looks cloudy, discoloured, or has particles.
Croatian: Nemojte koristiti ako otopina izgleda zamućeno, ako je promijenila boju, ili sadrži čestice.
English: Do not pull the cap off while holding the pre-filled syringe by the plunger.
Croatian: Nemojte skidati kapicu igle dok držite napunjenu štrcaljku za klip.
English: The recommended dose of Tegsedi is one dose of 284 mg inotersen.
Croatian: Preporučena doza lijeka Tegsedi je jedna doza od 284 mg inotersena.
English: Inotersen must not be used in patients with severe hepatic impairment (see section 4.3).
Croatian: Inotersen se ne smije primjenjivati u bolesnika s teškim oštećenjem funkcije jetre (vidjeti dio 4.3).
English: Your pre-filled syringe may make a click sound as you push the plunger down.
Croatian: Dok pritišćete klip napunjene štrcaljke prema dolje, možda začujete klik.
English: Toxicology
Croatian: Toksičnost
English: Do not let go of the plunger.
Croatian: Nemojte puštati klip.
English: Push the plunger down
Croatian: Pritisnite klip prema dolje
English: It is important to rotate sites for injection.
Croatian: Važno je kružno mijenjati mjesto injekcije.
English: The pharmacokinetics of inotersen in patients with hepatic impairment has not been studied.
Croatian: Farmakokinetika inotersena u bolesnika s oštećenjem funkcije jetre nije ispitana.
English: Both excess and deficient levels of vitamin A can harm the development of your unborn child.
Croatian: A mogu štetiti razvoju Vašeg nerođenog djeteta.
English: PREPARATION
Croatian: PRIPREMA
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Tegsedi 284 mg injection inotersen
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Tegsedi 284 mg injekcija inotersen s.c.
English: Plasma vitamin A (retinol) levels below lower limit of normal should be corrected and any ocular symptoms or signs of vitamin A deficiency should have resolved prior to initiation of inotersen.
Croatian: Potrebno je korigirati razine vitamina A (retinola) u plazmi koje su ispod donje granice normalnih vrijednosti, kao i okularne simptome ili znakove nedostatka vitamina
English: Needle Cap
Croatian: Kapica igle
English: Inotersen was not evaluated in patients undergoing liver transplantation in clinical trials (section 4.2).
Croatian: U kliničkim se ispitivanjima inotersen nije procjenjivao u bolesnika kojima se presađivala jetra (dio 4.2).
English: Do not put the needle cap back onto the pre-filled syringe.
Croatian: Nemojte vraćati kapicu igle na napunjenu štrcaljku.
English: Inotersen is associated with reductions in platelet count, which may result in thrombocytopenia.
Croatian: Inotersen je povezan sa smanjenjem broja trombocita, što može rezultirati trombocitopenijom.
English: Platelet count, estimated glomerular filtration rate (eGFR), urine protein to creatinine ratio (UPCR) and hepatic enzymes should be measured prior to treatment with Tegsedi.
Croatian: Prije početka primjene lijeka Tegsedi potrebno je izmjeriti broj trombocita, procijenjenu brzinu glomerularne filtracije (eGFR), omjer proteina i kreatinina u urinu (UPCR) te jetrene enzime.
English: Lift thumb slowly back up
Croatian: Polako podignite palac
English: Tegsedi contains the active substance inotersen.
Croatian: Tegsedi sadrži djelatnu tvar inotersen.
English: Orthostatic hypotension Hypotension Haematoma
Croatian: Poremećaji živčanog sustava glavobolja Krvožilni poremećaji ortostatska hipotenzija hipotenzija hematom
English: It is not known whether vitamin A supplementation in pregnancy will be sufficient to prevent vitamin A deficiency if the pregnant female continues to receive inotersen.
Croatian: A u trudnoći biti dovoljna za sprječavanje nedostatka vitamina
English: What you need to know before you use Tegsedi Do not use Tegsedi if: - you are allergic to inotersen or any of the other ingredients of this medicine (listed in section - tests show you have excessively low numbers of platelets, the cells in your blood which stick together helping it clot - tests of kidney function or protein in the urine show signs of severe kidney problems - you have severe reduction in liver function (hepatic impairment) Warnings and precautions Before you begin treatment with Tegsedi, your doctor will measure your blood cells, liver function, kidney function, and protein levels in your urine.
Croatian: Nemojte primjenjivati Tegsedi: - ako ste alergični na inotersen ili neki drugi sastojak ovog lijeka (naveden u dijelu 6). - pretrage pokazuju da imate prekomjerno niski broj trombocita, krvnih stanica koje se lijepe zajedno pomažući zgrušavanje krvi - pretrage funkcije bubrega ili proteina u mokraći pokazuju znakove teških problema s bubrezima - imate jako smanjenu funkciju jetre (oštećenje jetrene funkcije)
English: PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TRAY TEAR-OFF LID
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP POKROV PODLOŠKA KOJI SE MOŽE ODLIJEPITI
English: In addition, reduced thymus weight due to lymphocyte depletion was observed in mice and rats.
Croatian: Nadalje, u miševa i štakora opažena je smanjena težina timusa zbog deplecije limfocita.
English: In the Phase 3, NEURO-TTR trial, platelet count reductions to below normal (140 x 109/L ) were observed in 54% of patients treated with inotersen and 13% of placebo patients; reductions to below 100 x 10
Croatian: U fazi 3 ispitivanja NEURO-TTR, smanjenja broja trombocita ispod normalne vrijednosti (140x109/l) opažena su u 54% bolesnika liječenih inotersenom i 13% bolesnika na placebu; smanjenja ispod 100x109/l opažena su u 23% bolesnika liječenih inotersenom i 2% bolesnika koji su primali placebo; potvrđeni broj trombocita od <75x109/l opažen je u 10,7% bolesnika liječenih inotersenom.
English: - Each pre-filled syringe contains 284mg of inotersen.
Croatian: - Jedna napunjena štrcaljka sadrži 284 mg inotersena.
English: Symptoms of low vitamin A include:
Croatian: Simptomi niskog vitamina
English: V30M TTR mutation1, n (%)
Croatian: V30M TTR mutacija
English: Women of child-bearing age
Croatian: Žene reproduktivne dobi
English: Prepare to use your pre-filled syringe
Croatian: Pripremite napunjenu štrcaljku za uporabu
English: Patients who discontinue therapy with inotersen due to platelet counts below 25 x 10
Croatian: Bolesnici koji prekinu liječenje intersenom jer je broj trombocita ispod 25x109/l ne smiju ponovno započeti liječenje.
English: Do not throw away the pre-filled syringe in your household waste.
Croatian: Nemojte ih bacati u kućni otpad.
English: • Advise HCPs that if glomerulonephritis is confirmed, Tegsedi treatment should be permanently discontinued and early initiation of immunosuppressive therapy should be considered.
Croatian: • napomenuti zdravstvenim radnicima da je potrebno trajno prekinuti liječenje lijekom Tegsedi i razmotriti rani početak imunosupresivne terapije, ako je glomerulonefritis potvrđen.
English: No dose adjustment is required for patients with mild or moderate hepatic impairment (see section 5.2).
Croatian: Nije potrebno prilagođavati dozu u bolesnika s blagim ili umjerenim oštećenjem funkcije jetre (vidjeti dio 5.2).
English: The primary efficacy endpoints were the change from baseline to Week 66 in the modified Neuropathy Impairment Score + 7 tests (mNIS+7) composite score and in the Norfolk Quality of Life - Diabetic Neuropathy (QoL-DN) questionnaire total score.
Croatian: Modified Neuropathy Impairment Score + 7, mNIS+7) i ukupnom rezultatu Norfolk upitnika o kvaliteti života - dijabetička neuropatija (engl.
English: Skin and subcutaneous disorders
Croatian: Poremećaji kože i potkožnog tkiva svrbež osip
English: - Any medicines that may alter your kidney function or may damage the kidneys, e.g., sulfonamides (used as an antibacterial), anilides (used to treat fever, aches and pains), aldosterone antagonists (used as a diuretic) and natural opium alkaloids and other opiods (used for treatment of pain).
Croatian: - lijekovi koji sprječavaju stvaranje ugrušaka ili smanjuju broj trombocita u krvi, npr. acetilsalicilatna kiselina, heparin, varfarin,klopidogrel, rivoraksaban i dabigatran. - bilo koji lijekovi koji bi mogli promijeniti funkciju bubrega ili štete bubrezima, npr. sulfonamidi (koriste se protiv bakterija), anilidi (koriste se za liječenje vrućice i bolova), antagonisti aldosterona (koriste se kao diuretici) i prirodni alkaloidi opijuma i drugi opioidi (koriste se za liječenje bolova).
English: The plunger can feel stiff towards the end of the injection.
Croatian: Pri kraju injekcije može postati teže potiskivati klip.
English: Glomerulonephritis has occurred in patients treated with inotersen (see section 4.8).
Croatian: U bolesnika liječenih inotersenom razvio se glomerulonefritis (vidjeti dio 4.8).
English: See Section 4.8 for how to report adverse reactions
Croatian: Za postupak prijavljivanja nuspojava vidjeti dio 4.8.
English: ‡ Additional risk factors for bleeding include age >60 years, receiving anticoagulant or antiplatelet medicinal products, and /or prior history of major bleeding events † It is strongly recommended that, unless corticosteroids are contraindicated, the patient receives glucocorticoid therapy to reverse the platelet decline.
Croatian: ‡ Dodatni rizični čimbenici za krvarenje uključuju dob >60 godina, primanje antikoagulacijskih ili antitrombocitnih lijekova i/ili događaje velikog krvarenja u povijesti bolesti
English: • Remove the pre-filled syringe from the tray by holding onto the syringe body.
Croatian: • Napunjenu štrcaljku izvadite iz podloška tako da je primite za tijelo štrcaljke.
English: Liver Transplant Rejection
Croatian: Odbacivanje presatka jetre
English: If a dose of inotersen is missed, then the next dose should be administered as soon as possible, unless the next scheduled dose is within two days, in which case the missed dose should be skipped and the next dose administered as scheduled.
Croatian: U slučaju propuštanja doze inotersena, potrebno je primijeniti dozu što prije, osim ako je sljedeća planirana doza unutar dva dana.
English: Tegsedi 284 mg solution for injection in pre-filled syringe inotersen
Croatian: Tegsedi 284 mg otopina za injekciju u napunjenoj štrcaljki inotersen
English: It is not known whether vitamin A supplementation will be sufficient to reduce the risk to the foetus (see section 4.4).
Croatian: A biti dovoljna za smanjenje rizika za plod (vidjeti dio 4.4).
English: How to use Tegsedi
Croatian: Kako primjenjivati Tegsedi
English: Patients receiving inotersen should take oral supplementation of approximately 3,000 IU vitamin A per day in order to reduce the potential risk of ocular toxicity due to vitamin A deficiency.
Croatian: Bolesnici koji dobivaju inotersen trebaju uzimati peroralno suplementaciju od približno 3000 IU vitamina
English: CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Croatian: Lijek se izdaje na ograničeni recept (vidjeti Prilog I.: Sažetak opisa svojstava lijeka, dio 4.2.).
English: Serious side effects If you get any of the following side effects, stop using Tegsedi and contact your doctor immediately: - Symptoms that could indicate glomerulonephritis, (where your kidneys do not work properly), such as foaming urine, pink or brown coloured urine, blood in the urine, or passing less urine than usual.
Croatian: Ako dobijete bilo koju od sljedećih nuspojava, prestanite koristiti Tegsedi i odmah se obratite svojem liječniku: - simptomi koji mogu ukazivati na glomerulonefritis (kada vaši bubrezi ne rade ispravno), kao što je pjenjenje mokraće, ružičasto ili smeđe obojana mokraća, krv u mokraći, ili manje mokraće nego obično; - simptomi koji mogu ukazivati na trombocitopeniju (kada se krv ne zgrušava), kao neobjašnjiv nastanak modrica ili osip u obliku malih crvenih mrlja koje se pojavljuju na koži (nazivaju se petehije), krvarenje iz posjekotina na koži koje ne prestaje ili curi, krvarenje desni ili iz nosa, krv u mokraći ili stolici, ili krvarenje iz bjeloočnica.
English: Liver monitoring
Croatian: Učestalost praćenja
English: Then monitor twice weekly until 3 successive values above 75.
Croatian: Zatim pratiti dvaput tjedno do postizanja 3 puta zaredom vrijednosti iznad 75. Zatim tjedno praćenje do postizanja stabilnosti.
English: No recommendation can be given whether to continue or discontinue vitamin A supplementation during the first trimester of an unplanned pregnancy.
Croatian: Nije moguće dati preporuku o nastavku ili prekidu suplementacije vitaminom
English: Platelet and renal function tests should be monitored regularly.
Croatian: Potrebno je redovito obavljati pretrage radi praćenja broja trombocita i funkcije bubrega.
English: Glomerulonephritis / renal function decline
Croatian: Glomerulonefritis/smanjena funkcija bubrega
English: • Advise HCPs that if the platelet count falls below 25 x 109/L, Tegsedi treatment should be permanently discontinued and corticosteroid therapy is recommended;
Croatian: • napomenuti zdravstvenim radnicima da je potrebno trajno prekinuti liječenje lijekom Tegsedi i da se preporučuje liječenje kortikosteroidima ako broj trombocita padne ispod 25 x 109/l;
English: NAME OF THE MEDICINAL PRODUCT Tegsedi 284 mg solution for injection in pre-filled syringe
Croatian: NAZIV LIJEKA Tegsedi 284 mg otopina za injekciju u napunjenoj štrcaljki
English: How to store Tegsedi
Croatian: Kako čuvati Tegsedi
English: Blood and lymphatic system disorders
Croatian: Poremećaji krvi i limfnog sustava trombocitopenija anemija smanjen broj trombocita eozinofilija
English: Insert the needle
Croatian: Zabodite iglu
English: Glomerulonephritis / kidney problems
Croatian: Glomerulonefritis/problemi s bubrezima
English: Press down again if the plunger does not start to lift automatically.
Croatian: Ako se klip ne počne automatski sam podizati, ponovno ga pritisnite prema dolje.
English: Remove needle cap by pulling it straight off. Do not twist it off.
Croatian: Skinite kapicu igle tako da je povučete ravno.
English: Influenza like illness Peripheral swelling Injection site discolouration
Croatian: Opći poremećaji i reakcije na mjestu primjene vrućica zimica reakcije na mjestu injiciranja periferni edem bolest nalik gripi periferno oticanje promjena boje na mjestu injiciranja
English: Pull to open
Croatian: Otvoriti povlačenjem
English: Cases of liver transplant rejection have been reported in patients being treated with Tegsedi.
Croatian: U bolesnika liječenih lijekom Tegsedi prijavljeni su slučajevi odbacivanja presatka jetre.
English: Reporting of side effects
Croatian: Pregled sastavnih dijelova
English: Transaminases increased
Croatian: Poremećaji jetre i žuči povišene transaminaze
English: NAME OF THE MEDICINAL PRODUCT Tegsedi 284 mg solution for injection in pre-filled syringe inotersen NAME OF THE MARKETING AUTHORIZATION HOLDER Akcea Therapeutics EXPIRY DATE
Croatian: NAZIV LIJEKA Tegsedi 284 mg otopina za injekciju u napunjenoj štrcaljki inotersen NAZIV NOSITELJA
English: - If you get any side effects, talk to your doctor, pharmacist or or nurse.
Croatian: - Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, ljekarnika ili medicinsku sestru.
English: Hepatic impairment
Croatian: Ozbiljne nuspojave
English: Discontinuation of Inotersen should be considered in patients who develop liver transplant rejection during treatment.
Croatian: Potrebno je razmotriti prekid liječenja inotersenom u bolesnika kod kojih se pojavi odbacivanje presatka jetre.
English: Baseline n
Croatian: Početna vrijednost n
English: It is normal to see air bubbles in the solution.
Croatian: Prisutnost mjehurića zraka u otopini je normalna.
English: Needle
Croatian: Inotersen
English: Norfolk QoL-DN, mean (SD) Disease stage, n (%)
Croatian: Norfolk Quality of Life - Diabetic Neuropathy, QoL-DN).
English: Your doctor will ask you to take a daily vitamin A supplement during treatment with Tegsedi.
Croatian: Liječnik će Vam propisati uzimanje dodataka vitamina
English: How to store Tegsedi 6.
Croatian: Kako primjenjivati Tegsedi 4. Moguće nuspojave
English: Vomiting Nausea
Croatian: Prijavljivanje nuspojava
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each pre-filled syringe contains 284 mg inotersen (as sodium).
Croatian: Jedna napunjena štrcaljka sadrži 284 mg inotersena (u obliku inotersennatrija).
English: Acute kidney injury Renal impairment
Croatian: Često mokraćnog sustava proteinurija zatajivanje bubrega akutno zatajenje bubrega Oštećenje funkcije bubrega
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Akcea Therapeutics Ireland Ltd
Croatian: ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Akcea Therapeutics ROK VALJANOSTI
English: Dose adjustment in case of reduction in platelet count Inotersen is associated with reductions in platelet count, which may result in thrombocytopenia.
Croatian: Prilagođavanje doze u slučaju smanjenja broja trombocita
English: Percent Change from Baseline in Serum TTR Over Time
Croatian: Slika 1 Postotna promjena od početne vrijednosti TTR-a u serumu tijekom vremena Klinička djelotvornost i sigurnost
English: Glomerulonephritis Proteinuria Renal failure
Croatian: Poremećaji bubrega i glomerulonefritis
English: Chills
Croatian: Placebo
English: Cases of liver transplant rejection have been reported in patients treated with Inotersen.
Croatian: U bolesnika liječenih inotersenom prijavljeni su slučajevi odbacivanja presatka jetre.
English: SC
Croatian: TTR
English: INJECTION 6.
Croatian: INJEKCIJA 6. Skinite kapicu igle
English: You should resume the vitamin A supplementation during your second and third trimesters of your pregnancy if your vitamin A levels have not yet returned to normal, because of the increased risk of vitamin A deficiency in the third trimester.
Croatian: Zbog povećanog rizika nedostatka vitamina A u trećem tromjesečju, trebate nastaviti s uzimanjem dodataka vitamina
English: This summary was last updated in December 2013.
Croatian: Sažetak je posljednji put dopunjen u prosincu 2013.
English: Contacera meloxicam
Croatian: Contacera meloksikam
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Contacera on 6 December 2012.
Croatian: Europska komisija dodijelila je odobrenje za stavljanje u promet koje je na snazi na teritoriju Europske unije za proizvod Contacera dana 6. studenog 2012. godine.
English: Other information about Contacera:
Croatian: Druge informacije o VMP-u Contacera:
English: It is available as a solution for injection (20 mg/ml) and an oral suspension (15 mg/ml).
Croatian: Dostupan je kao otopina za injekciju (20 mg/ml) i oralna suspenzija (15 mg/ml).
English: The product is not authorised for use in horses producing milk for human consumption.
Croatian: Ovaj proizvod nije odobren za primjenu u konja koji se koriste za proizvodnju mlijeka za ljudsku uporabu.
English: People who are hypersensitive to NSAIDs should avoid contact with Contacera.
Croatian: Osobe koje su preosjetljive na NSAID-ove trebaju izbjegavati kontakt s VMP-om Contacera.
English: Septicaemia and toxaemia are conditions where bacteria circulate in the blood and produce harmful substances (toxins).
Croatian: Septikemija i toksemija su stanja u kojima bakterija cirkulira u krvi i proizvodi štetne tvari (toksine).
English: In horses, a temporary swelling at the injection site can occur but resolves without intervention.
Croatian: U konja može nastupiti privremeno oticanje u mjestu injekcije, no ono nestaje bez intervencije.